{"symbol": "ATMS", "name": "Artemis Therapeutics", "next_earnings_utc": 1592316000, "next_earnings_period_start_date_utc": null, "next_earnings_period_end_date_utc": null, "next_earnings_has_time": true, "next_earnings_name": "None QNone", "next_earnings_year": null, "next_earnings_quarter": null, "next_earnings_revenue_num_analysts": null, "next_earnings_revenue_consensus": null, "next_earnings_eps_num_analysts": null, "next_earnings_eps_consensus": null, "eps_up_revisions": null, "eps_down_revisions": null, "revenue_up_revisions": null, "revenue_down_revisions": null, "total_analysts": 0, "analysts_sell": null, "analysts_buy": null, "analysts_outperform": null, "analysts_hold": null, "analysts_underperform": null, "webpage": "artemis-therapeutics.com", "year_founded": 1997, "street_address": "18 East 16th Street", "city": "New York", "state": "NY", "zipcode": "10003", "country": "United States", "phone_number": "646-233-1454", "short_description": "Artemis Therapeutics Inc. does not have significant operations.", "long_description": "Artemis Therapeutics Inc. does not have significant operations. Previously, it was engaged in the development of agents for the prevention and treatment of severe and life-threatening infectious diseases. The company was incorporated in 1997 and is based in New York, New York.", "industry_name": null, "sector_name": null, "is_defunct": false, "exchange": "OTCQB", "equity_type": "stocks", "market_cap": 180886, "total_enterprise": 283886, "number_of_employees": 1, "outstanding_shares": 5153461, "eps": -0.019986, "diluted_eps": -0.019986, "earnings_from_cont_operations": -121000, "gross_profit": null, "cash": 2000, "total_debt": 105000, "total_revenue": null, "cash_from_operations": -105000, "net_income": -121000, "ebitda": null, "year_low_stock_price": 0.032, "year_high_stock_price": 0.45, "seekingalpha_follower_count": 33, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/ATMS.png"}